Sacramento-based Insera Therapeutics Inc. says it's ready to ramp up to commercialization now that it has approval to bring its medical device to Europe.
After nearly a decade developing a device for “minimally-invasive brain surgery” to remove blood clots during a stroke, the company recently received approval from the European Commission for its flagship product, CEO Vikram Janardhan said.
“We’re just coming out of stealth mode,” Janardhan said, adding that the approval is a major…
